Effective Health Care Research Consortium,
Preventing active tuberculosis (TB) from developing in people with latent TB infection is important for global TB control. Read…
Preventing active tuberculosis (TB) from developing in people with latent TB infection is important for global TB control. Read…
Current treatment recommendations for treating dormant or latent #TB favors the use of #Isoniazid for six months. Are there…
Current treatment recommendations for treating dormant or latent #TB favors the use of #Isoniazid for six months. Are there…
Current treatment recommendations for treating dormant or latent #TB favors the use of #Isoniazid for six months. Are there…
Sharma SK, Sharma A, Kadhiravan T, Tharyan PPublished Online: July 5, 2013Tuberculosis (TB) is a disease that is caused by a…
Current treatment recommendations for treating dormant or latent TB favors the use of Isoniazid for six months. Are there…
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at…